Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients.

Maasoumy, Benjamin; Buggisch, Peter; Mauss, Stefan; Boeker, Klaus H W; Müller, Tobias; Günther, Rainer; Zimmermann, Tim; Manns, Michael P; Sarrazin, Christoph; Hüppe, Dietrich; Wedemeyer, Heiner; Vermehren, Johannes.
Liver Int; 38(11): 1906-1910, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30022590